Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Video of Jamshid Maddahi, MD, UCLA, explaining why flurpiridaz will change cardiac imaging and increase the adoption of PET cardiac imaging.

A closer look at how FDA's flurpiridaz approval will impact nuclear cardiology

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

long covid brainstem damage

Ultra-high field MRI implicates long COVID in brainstem damage

Researchers have used 7T MRI to demonstrate that former COVID-19 inpatients are susceptible to persistent brainstem abnormalities associated with long-haul COVID symptoms.

artificial intelligence healthcare industry digest

ChatGPT is overly worried about ED patients

The popular AI chatbot tends to over-order X-rays, prescribe too many antibiotics and admit too many patients to the hospital when compared with a resident emergency department physician. 

Banner ASC in Sun City, Arizona.

Low doses of radiation still increase risk of leukemia, lymphoma and myeloma

A new study found cumulative radiation exposure of 16 mSv to red bone marrow can cause an increased rate of some hematological malignancies.

Is ultrasound necessary for all interventional procedures requiring femoral artery access?

Several such IR procedures require US guidance, but a new study is questioning the modality’s effectiveness in reducing complication rates. 

Thumbnail

Incidental finding characteristics that warrant communication

Three factors are associated with true high-risk findings—imaging protocols for aortic valve implantation planning, imaging area, and cardiology department orders.

AURORA trial results for Flurpiridaz F-18 PET vs. SPECT discussed by principal investigator Jamshid Maddahi, MD.

'This could be a paradigm shift': How PET with newly approved flurpiridaz compares to SPECT

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

breast cancer screening mammography

AI accurately predicts breast cancer years before diagnosis

This information could help providers personalize breast cancer screening strategies and initiate treatment earlier.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.